taxonomy (1)
protein (1)
source (3)
structure (0)
composition (68)
disease (2)
reference (3)
site (1)
peptide (1)
- Homo sapiens (Human)
Taxonomy
- Fibronectin / Homo sapiens P02751
Protein
Reported structure
- Hex:3 HexNAc:3 dHex:1 (avg mass : 1260.1705 )
- Hex:3 HexNAc:4 NeuAc:1 (avg mass : 1608.4804 )
- Hex:3 HexNAc:4 NeuAc:2 (avg mass : 1899.7383 )
- Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
- Hex:3 HexNAc:5 dHex:1 (avg mass : 1666.5605 )
- Hex:3 HexNAc:6 dHex:2 (avg mass : 2015.8985 )
- Hex:3 HexNAc:6 dHex:2 NeuAc:1 (avg mass : 2307.1564 )
- Hex:3 HexNAc:7 dHex:1 (avg mass : 2072.9505 )
- Hex:3 HexNAc:8 (avg mass : 2130.0025 )
- Hex:4 HexNAc:3 dHex:1 (avg mass : 1422.3129 )
- Hex:4 HexNAc:3 dHex:3
- Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 1916.7658 )
- Hex:4 HexNAc:4 dHex:2 (avg mass : 1771.6509 )
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2062.9088 )
- Hex:4 HexNAc:4 dHex:3 (avg mass : 1917.7939 )
- Hex:4 HexNAc:5 NeuAc:2 (avg mass : 2265.0757 )
- Hex:4 HexNAc:5 dHex:1 (avg mass : 1828.7029 )
- Hex:4 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2119.9608 )
- Hex:4 HexNAc:5 dHex:3 (avg mass : 2120.9889 )
- Hex:4 HexNAc:6 (avg mass : 1885.7549 )
- Hex:4 HexNAc:6 dHex:1 (avg mass : 2031.8979 )
- Hex:4 HexNAc:6 dHex:2 (avg mass : 2178.0409 )
- Hex:4 HexNAc:7 dHex:1 (avg mass : 2235.0929 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:3 dHex:1 (avg mass : 1584.4553 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:2 (avg mass : 1933.7933 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
- Hex:5 HexNAc:4 dHex:3 (avg mass : 2079.9363 )
- Hex:5 HexNAc:5 (avg mass : 1844.7023 )
- Hex:5 HexNAc:5 dHex:1 (avg mass : 1990.8453 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2282.1032 )
- Hex:5 HexNAc:5 dHex:3 (avg mass : 2283.1313 )
- Hex:5 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2485.2982 )
- Hex:6 HexNAc:4 (avg mass : 1803.6497 )
- Hex:6 HexNAc:4 NeuAc:1 (avg mass : 2094.9076 )
- Hex:6 HexNAc:4 dHex:1 (avg mass : 1949.7927 )
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2241.0506 )
- Hex:6 HexNAc:4 dHex:2 (avg mass : 2095.9357 )
- Hex:6 HexNAc:4 dHex:3 (avg mass : 2242.0787 )
- Hex:6 HexNAc:5 (avg mass : 2006.8447 )
- Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
- Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
- Hex:6 HexNAc:5 dHex:1 (avg mass : 2152.9877 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2444.2456 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:6 HexNAc:5 dHex:2 (avg mass : 2299.1307 )
- Hex:6 HexNAc:5 dHex:3 (avg mass : 2445.2737 )
- Hex:6 HexNAc:5 dHex:3 NeuAc:1
- Hex:6 HexNAc:6 (avg mass : 2210.0397 )
- Hex:6 HexNAc:6 NeuAc:1 (avg mass : 2501.2976 )
- Hex:6 HexNAc:6 NeuAc:2 (avg mass : 2792.5555 )
- Hex:7 HexNAc:4 dHex:1 (avg mass : 2111.9351 )
- Hex:7 HexNAc:6 (avg mass : 2372.1821 )
- Hex:7 HexNAc:6 NeuAc:2 NeuGc:1 (avg mass : 3261.9552 )
- Hex:7 HexNAc:6 dHex:1 (avg mass : 2518.3251 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 3100.8409 )
- Hex:7 HexNAc:7 dHex:4 (avg mass : 3159.9491 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
- Hex:12 HexNAc:2 (avg mass : 2370.1141 )
Composition
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
Reference
- Fibronectin / Homo sapiens
Reported glycosite
- DQCIVDDITYNVNDTFHK (18aa)
Mass spectrometry observed peptide
-
- Hex:5 HexNAc:2 / N-Linked (avg mass : 1235.1173)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:3 HexNAc:3 dHex:1 / N-Linked (avg mass : 1260.1705)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:3 dHex:1 / N-Linked (avg mass : 1422.3129)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:3 HexNAc:4 dHex:1 / N-Linked (avg mass : 1463.3655)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:3 dHex:3 / N-Linked
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:3 dHex:1 / N-Linked (avg mass : 1584.4553)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:3 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1608.4804)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:4 dHex:1 / N-Linked (avg mass : 1625.5079)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:4 / N-Linked (avg mass : 1641.5073)
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:3 HexNAc:5 dHex:1 / N-Linked (avg mass : 1666.5605)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:8 HexNAc:2 / N-Linked (avg mass : 1721.5445)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:4 dHex:2 / N-Linked (avg mass : 1771.6509)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:4 dHex:1 / N-Linked (avg mass : 1787.6503)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:4 / N-Linked (avg mass : 1803.6497)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:5 dHex:1 / N-Linked (avg mass : 1828.7029)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:5 / N-Linked (avg mass : 1844.7023)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:9 HexNAc:2 / N-Linked (avg mass : 1883.6869)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:6 / N-Linked (avg mass : 1885.7549)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:3 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 1899.7383)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 1916.7658)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:4 dHex:3 / N-Linked (avg mass : 1917.7939)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1932.7652)
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:4 dHex:2 / N-Linked (avg mass : 1933.7933)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:4 dHex:1 / N-Linked (avg mass : 1949.7927)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:5 dHex:1 / N-Linked (avg mass : 1990.8453)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:5 / N-Linked (avg mass : 2006.8447)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:3 HexNAc:6 dHex:2 / N-Linked (avg mass : 2015.8985)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:6 dHex:1 / N-Linked (avg mass : 2031.8979)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2062.9088)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:3 HexNAc:7 dHex:1 / N-Linked (avg mass : 2072.9505)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2078.9082)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:4 dHex:3 / N-Linked (avg mass : 2079.9363)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 2094.9076)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:4 dHex:2 / N-Linked (avg mass : 2095.9357)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:7 HexNAc:4 dHex:1 / N-Linked (avg mass : 2111.9351)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:5 dHex:1 NeuAc:1 / N-Linked (avg mass : 2119.9608)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:5 dHex:3 / N-Linked (avg mass : 2120.9889)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:3 HexNAc:8 / N-Linked (avg mass : 2130.0025)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:5 dHex:1 / N-Linked (avg mass : 2152.9877)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:6 dHex:2 / N-Linked (avg mass : 2178.0409)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:6 / N-Linked (avg mass : 2210.0397)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2225.0512)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:7 dHex:1 / N-Linked (avg mass : 2235.0929)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2241.0506)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:4 dHex:3 / N-Linked (avg mass : 2242.0787)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:5 NeuAc:2 / N-Linked (avg mass : 2265.0757)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 / N-Linked (avg mass : 2282.1032)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:5 dHex:3 / N-Linked (avg mass : 2283.1313)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked (avg mass : 2298.1026)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:5 dHex:2 / N-Linked (avg mass : 2299.1307)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:3 HexNAc:6 dHex:2 NeuAc:1 / N-Linked (avg mass : 2307.1564)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:12 HexNAc:2 / N-Linked (avg mass : 2370.1141)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked (avg mass : 2370.1661)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:7 HexNAc:6 / N-Linked (avg mass : 2372.1821)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 / N-Linked (avg mass : 2444.2456)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:5 dHex:3 / N-Linked (avg mass : 2445.2737)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:6 dHex:1 NeuAc:1 / N-Linked (avg mass : 2485.2982)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:5 dHex:3 NeuAc:1 / N-Linked
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:6 NeuAc:1 / N-Linked (avg mass : 2501.2976)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:7 HexNAc:6 dHex:1 / N-Linked (avg mass : 2518.3251)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 / N-Linked (avg mass : 2735.5035)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:6 NeuAc:2 / N-Linked (avg mass : 2792.5555)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:5 NeuAc:3 / N-Linked (avg mass : 2880.6184)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 / N-Linked (avg mass : 3026.7614)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 / N-Linked (avg mass : 3100.8409)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:7 HexNAc:7 dHex:4 / N-Linked (avg mass : 3159.9491)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:7 HexNAc:6 NeuAc:2 NeuGc:1 / N-Linked (avg mass : 3261.9552)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
